Recent developments in hyperthyroidism

The Lancet

Volumn 373, Issue 9679, 2009, Pages 1930-1932

  Kharlip, Julia ^a   Cooper, David S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; FLUORODEOXYGLUCOSE; LIOTHYRONINE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ARTICLE; CLINICAL TRIAL; GRAVES DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; LIOTHYRONINE BLOOD LEVEL; MEDICAL DECISION MAKING; MEDICAL RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SURGICAL TECHNIQUE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

EID: 66149169958     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61047-3     Document Type: Note

References (14)

1. Cooper D.S. Hyperthyroidism. Lancet 362 (2003) 459-468
2. Cappola A.R., Fried L.P., Arnold A.M., et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295 (2006) 1033-1041
3. Haentjens P., Van Meerhaeghe A., Poppe K., and Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol 159 (2008) 329-341
4. Tauchmanova L., Nuzzo V., Del Puente A., et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas 48 (2004) 299-306
5. Sun L., Davies T.F., Blair H.C., Abe E., and Zaidi M. TSH and bone loss. Ann NY Acad Sci 1068 (2006) 309-318
6. Schreckenberger M.F., Egle U.T., Drecker S., et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab 91 (2006) 4786-4791
7. Carani C., Isidori A.M., Granata A., et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 90 (2005) 6472-6479
8. Bousquet-Santos K., Vaisman M., Barreto N.D., et al. Resistance training improves muscle function and body composition in patients with hyperthyroidism. Arch Phys Med Rehabil 87 (2006) 1123-1130
9. Nakamura H., Noh J.Y., Itoh K., Fukata S., Miyauchi A., and Hamada N. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 92 (2007) 2157-2162
10. Abraham P., Avenell A., Watson W.A., Park C.M., and Bevan J.S. Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev 2 (2005) CD003420.
11. Walter M.A., Briel M., Christ-Crain M., et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ 334 (2007) 514-521
12. Rodien P. Rituximab in Graves' disease. Eur J Endocrinol 159 (2008) 515-516
13. Laurberg P., Wallin G., Tallstedt L., Abraham-Nordling M., Lundell G., and Torring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158 (2008) 69-75
14. Abraham-Nordling M., Torring O., Hamberger B., et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid 15 (2005) 1279-1286